Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Pneumonia, Wheezing
Clinical narrative: A report was received from a consumer on 05/04/04 who is a 54 year old female vaccinee who experienced influenza, which was considered disabling, approximately 2 weeks after receiving Fluvirin and Pneumonia vaccine (unspecified) on 10/20/03 into seperate arms. The vaccine also experienced pneumonia, which was considered disabling an unspecified length of time after receiving Fluvirin and an unspecified pneumonia vaccine on 10/20/03.  The vaccine had received influenza vaccine for several years without any issues.  On 11/03/03 the vaccinee experienced a sore raspy throat and felt unwell after receiving Fluvirin and a pneumococcal vaccine on 10/20/03 in different arms.  The vaccinee's sore throat became extremely painful and she visited the ER on  11/09/03.  A throat culture was taken, which concluded that the vaccinee did not have a streptococcal throat.  The vaccinee was subsequently diagnosed as having the flu and was prescribed Levofloxacin and an unspecified cough medication with codeine to help with the painful sore throat.  On 11/1/03, the vaccinee had a follow up appointment with her treating physician as she had developed severe chest congestion.  The vaccinee received an unspecified steroid injection at the clinic and was prescribed a course of Prednisone therapy.  On 11/19/03, the vaccinee returned to her treating physician's office and complained of severe head congestion and was subsequently prescribed amoxicillin and albuterol. The vaccinee developed diarrhea from the amoxicillin. Throughout this period of time the vaccinee was unable to work. The vaccinee visited the physician's office again on 12/15/03 and between this appointment and the last visit she reported that her lungs felt like they were on fire.  the physician stated that her lungs sounded clear and prescribed montelukast sodium and stated that she was to continue albuterol therapy.  On 01/15/03, the vaccinee saw a lung specialist and had an X-ray which confirmed that her lungs were clear, however there was evidence of residual scarring that may have occurred cue to the pneumonia. The vaccinee returned to work on 02/16/04, however she continued to experience fatigue.  Due to her continued fatigue she quit her job on 03/08/04.  On 03/24/04, the vaccinee visited her physician due to bouts of wheezing and returning symptoms of a sore throat.  The vaccinee was presribed albuterol and another course of amoxicillin.  On 04/05/04, the vaccinee returned to her physician with continued symptoms and was prescribed a course of azithromycin that relieved her symptoms.  At the time of the report the vaccinee continued to experience periods of wheezing and shortness of breath. The vaccinee is unsure if she just contracted flu or pneumonia, as anyone in contact with her has not contracted any illness from her.  However, this was her first exposure to the pneumonia vaccine. Follow up received 31Aug04 from a healthcare professional. The vaccinee was confirmed as a 54 year old female (height 5ft 4 inches; weight 161 pounds). The vaccinees medical history included allergies to Tetracycline, Doxycycline, Zyrtec, Celexa and Bellergal. Cardiac catheter in 1997, total abdominal hysterectomy in 1993 and anxiety disorder and mitral valve prolapse. Her concomitant medications included Buspar 15mg twice daily for depression; Ambien 5mg at bedtime for sleep disorder; Zovirax 20mg Prn, caltrate 600mg, Depakote 500mg twice daily for mental disorder; Nexium 20mg for influenza vaccine on 15Oct02.  On 20Oct03, the vaccinee received 0.5ml Fluvirin IM. Ten day later (on 09Nov03) the vaccinee was seen in the ER for sore throat, purulent drainage and cough, fever and hoarseness. She was diagnosed with acute bronchitis and tonsilitis. She was seen in follow up by her physician on 12Nov03, 19Nov03 and 15Dec03. The outcome was not reported. The reporter commented that none of the events were due to vaccination. The reporter does not indicate that these events were serious. A report was submitted to the authorities on 07Apr04 by the healthcare professional.